OncLive Nab-P/G is the first taxane-based therapy to show a significant improvement in overall survival (OS) in a phase III trial for patients with metastatic pancreatic cancer.1 The E/G regimen, initially approved in 2004, is among the newer options for … |
Source: NAB Show News From Google
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.